Login
$LH
$372.46 +$0.00 (0.0%) After hours

Company Executives

Officer Age In this role Joined Source
Adam H. Schechter Also a director
President & CEO
Title from the Form 4 dated Aug 11, 2026
61 Not stated Not stated
Julia A. Wang
Executive Vice President and Chief Financial Officer
55 Since 2024
2 years
Not stated
Jonathan C Meltzer
EVP, COO
Title from the Form 4 dated Sep 1, 2026
Not stated Not stated Not stated
Peter J. Wilkinson
Senior Vice President and Chief Accounting Officer
55 Since 2019
7 years
Not stated
Akinbolade Oyegunwa
EVP, CIO & CTO
Title from the Form 4 dated Nov 1, 2026
Not stated Not stated Not stated
Amy B. Summy
EVP, Chief Marketing Officer
Title from the Form 4 dated Aug 4, 2026
Not stated Not stated Not stated
Kathryn W Kyle
EVP, Chief Legal Officer
Title from the Form 4 dated Jul 1, 2026
Not stated Not stated Not stated
Brian J. Caveney
EVP, Pres of BLS, CMO & CSO
Title from the Form 4 dated Nov 10, 2026
Not stated Not stated Not stated
Bryan T. Vaughn
Executive Vice President, Diagnostics
43 Since 2026
this year
2009

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
11
serving now
Independent
9 of 10
stated in the proxy; 1 not stated
Average tenure
8.1 years
from year joined
CEO also chairs the board
Yes
Adam H. Schechter
Director Age On board Independent Other public boards 2025 pay Source
Adam H. Schechter
61 2013
13 years
Not independent DaVita Inc. Paid as CEO
Garheng Kong, M.D., Ph.D.
50 2013
13 years
Not stated Smith & Nephew plc, IKS Health (NSE:IKS), Lunit Inc. (KOSDAQ: 328130), Xeris Biopharma Holdings, Inc. (formerly Strongbridge Biopharma plc) $405,000
Kerrii B. Anderson
68 2006
20 years
Independent Worthington Enterprises, Inc., Abercrombie & Fitch Co., The Sherwin-Williams Company $340,000
Victor Bulto
47 2025
1 year
Independent None stated $46,776
Jeffrey A. Davis
62 2019
7 years
Independent None stated $365,000
Kirsten M. Kliphouse
59 2022
4 years
Independent Global Payments, Inc. $340,000
Peter M. Neupert
70 2013
13 years
Independent Adaptive Biotechnologies Corporation, Fortrea Holdings Inc. $340,000
Richelle P. Parham
58 2016
10 years
Independent Best Buy Co., Inc. $360,000
Paul B. Rothman, M.D.
68 2023
3 years
Independent Merck & Co. $360,000
John H. Sampson, M.D., Ph.D.
59 2026
this year
Independent None stated Not stated
Kathryn E. Wengel
60 2021
5 years
Independent None stated $340,000

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 10, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support